Works by Cesini, Laura
Results: 14
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).
- Published in:
- Annals of Hematology, 2019, v. 98, n. 2, p. 361, doi. 10.1007/s00277-018-3524-1
- By:
- Publication type:
- Article
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 5, p. 408, doi. 10.1159/000531101
- By:
- Publication type:
- Article
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Acute hepatitis-like presentation with cholestasis of CBFB-MYH11-positive acute myeloid leukemia in an adult male: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 286, doi. 10.1111/ejh.13436
- By:
- Publication type:
- Article
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 578, doi. 10.1111/ejh.13110
- By:
- Publication type:
- Article
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 2, p. 160, doi. 10.1111/ejh.13086
- By:
- Publication type:
- Article
Managing treatment-related peripheral neuropathy in patients with multiple myeloma.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2016, v. 6, p. 37, doi. 10.2147/BLCTT.S91251
- By:
- Publication type:
- Article
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2843, doi. 10.3390/cancers14122843
- By:
- Publication type:
- Article
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3214, doi. 10.3390/cancers13133214
- By:
- Publication type:
- Article
Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 660, doi. 10.1159/000502801
- By:
- Publication type:
- Article
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic.
- Published in:
- JAC-Antimicrobial Resistance, 2021, v. 3, n. 4, p. 1, doi. 10.1093/jacamr/dlab167
- By:
- Publication type:
- Article